HEPIONE THERAPEUTICS INC — Federal Contracts, Awards & Government Contractor Profile

About HEPIONE THERAPEUTICS INC

Hepione Therapeutics is a biotech startup developing monoclonal antibodies to prevent opioid overdose, particularly targeting fentanyl using its proprietary VAST platform technology. The company is based in New York City and focuses on generating high-affinity antibodies for small molecule opioids.

Development of monoclonal antibodies to prevent opioid overdoseUtilization of the VAST platform for generating antibodies to small moleculesCreation of high-affinity and selective fentanyl-neutralizing antibodiesPartnership with leading pharmaceutical companies for product development

Is this your company?

Claim HEPIONE THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim HEPIONE THERAPEUTICS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.